Toronto Stock Exchange Symbol: MS
EDMONTON, May 5 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), will hold its Annual General Meeting on Friday, May 9, 2008, at 2:00 p.m. (MT), 4:00 p.m. (ET).
A live audio webcast of the conference call will be available at http://www.biomsmedical.com. Please connect at least ten minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast.
Members of the professional investment community are invited to
participate in the conference call by telephone.
DATE: Friday, May 9, 2008
TIME: 2:00p.m. (Mountain Time), 4:00 p.m. (Eastern Time)
DIAL IN NUMBER: 416 644-3430 or 1 800-814-4857
TAPED REPLAY: 1 877-289-8525 or 416 640-1917; available from
May 9, 2008 until May 16, 2008 at midnight
REFERENCE NUMBER: 21271314
About BioMS Medical Corp.
------------------------- BioMS Medical is a biotechnology company engaged in the development and
commercialization of novel therapeutic technologies. BioMS Medical's lead
technology, MBP8298, is for the treatment of multiple sclerosis and is
being evaluated in two pivotal phase III clinical trials for secondary
progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in
the United States. It additionally is being evaluated for relapsing
remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. In
December 2007, BioMS entered into a licensing and development agreement
granting Eli Lilly and Company exclusive worldwide rights to MBP8298 in
exchange for an $87 million upfront payment, milestone payments and
escalating royalties on sales. For further information please visit our
|SOURCE BioMS Medical Corp.|
Copyright©2008 PR Newswire.
All rights reserved